Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at SGD 11.8B, ahead of BioNTech (SGD 11B) and Gilead Sciences (SGD 9.7B). Figures as of 18 Nov 2026, 22:37 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenSGD 11.8B
Median
SGD 558.2M
Combined market value
SGD 1.08T
Countries
5

Market values as of .

All countries
All sectors
Biotech
SGD
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSGD 11.8BSGD 309.5BSGD 572.12 3.07% down 34% up United States
2BioNTechBNTX · Health CareSGD 11BSGD 26.6BSGD 107.31 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareSGD 9.7BSGD 270.1BSGD 217.79 0.75% down 33% up United States
4argenxARGX · Health CareSGD 4.5BSGD 76.3BSGD 1,213.16 0.66% down 4% up Belgium
5BiogenBIIB · Health CareSGD 3.9BSGD 47.9BSGD 324.04 0.25% up 49% up United States
6ModernaMRNA · Health CareSGD 3.3BSGD 102.6BSGD 253.64 4.84% down 755% up United States
7ImmunovantIMVT · Health CareSGD 1.2BSGD 8.8BSGD 42.75 0.12% down 43% up United States
8QiagenQGEN · Health CareSGD 1.1BSGD 13.2BSGD 63.88 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareSGD 919MSGD 21.2BSGD 209.91 1.84% down 20% up United States
10RepligenRGEN · Health CareSGD 729.5MSGD 14.2BSGD 222.55 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareSGD 639.7MSGD 12BSGD 406.44 5.62% up 46% up United States
12ExelixisEXEL · Health CareSGD 621.9MSGD 21.5BSGD 88.02 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareSGD 494.6MSGD 44.6BSGD 205.99 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareSGD 460.1MSGD 13.3BSGD 156.12 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareSGD 448MSGD 5BSGD 51.80 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareSGD 417MSGD 7.5BSGD 61.87 6.48% up 14% up United States
17Bio-TechneTECH · Health CareSGD 341.2MSGD 14.7BSGD 93.77 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareSGD 270.5MSGD 8.2BSGD 126.07 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareSGD 235.9MSGD 10.2BSGD 149.96 3.88% up 340% up United States
20VaxcytePCVX · Health CareSGD 224.2MSGD 11.9BSGD 75.43 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareSGD 172.5MSGD 14.1BSGD 123.47 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareSGD 113.9MSGD 9.2BSGD 8.64 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareSGD 90.9MSGD 5.9BSGD 36.68 0.11% down 88% up United States
24CG OncologyCGON · Health CareSGD 41.9MSGD 9.2BSGD 103.11 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2889 SGD).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (SGD 11.8B), BioNTech (SGD 11B) and Gilead Sciences (SGD 9.7B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 22:37 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of SGD 1.08T as of 18 Nov 2026, 22:37 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.